"KIR2DL5A" Related Products

Recombinant Human KIR2DL5A Protein, Fc Chimera

Cat.No.: KIR2DL5A-728H
Product Overview: Recombinant Human KIR2DL5A (Accession # NP_065396), fused with , was produced in Mouse myeloma cell line, NS0-derived.
Source: NSO Cells
Species: Human
Tag: Fc
Predicted N Terminal: His22
Form: Lyophilized from a 0.2 µm filtered solution in PBS.
Bio-activity: Measured by its ability to bind HLA on MDA-MB-231 human breast cancer cells.The ED50 for this effect is typically 0.9 - 3.6 µg/mL. Optimal dilutions should be determined by each laboratory for each application.
Molecular Mass: Recombinant Human KIR2DL5A, Fc Chimera has a calculated MW of 50.1 kDa (monomer). In SDS-PAGE migrates as 66 kDa, reducing conditions.
Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
Gene Name: KIR2DL5A killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A [ Homo sapiens ]
Official Symbol: KIR2DL5A
Synonyms: KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A; CD158F; KIR2DL5; KIR2DL5.1;
Gene ID: 554278
mRNA Refseq:
Protein Refseq:
MIM: 605305
UniProt ID: Q8N109
Chromosome Location: 19q13.4

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.